Quantum BioPharma Corp (QNTM): Multiplikator rega marang pendapatan
Quantum BioPharma Ltd (QNTM) combines the development of dietary supplements with the outsourcing of testing to external laboratories, as confirmed by the P/S chart. The latest parameter stands at , capturing the market's price-to-sales valuation. To maintain its position in the saturated biotech sector, Quantum BioPharma Ltd (QNTM) is expanding its portfolio with sleep aids and pain management products.
Quantum BioPharma Limited (QNTM) - rincian metrik lan laporan keuangan
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- data kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas Quantum BioPharma Ltd|QNTM - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Quantum BioPharma Corp|QNTM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Quantum BioPharma Limited|QNTM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Quantum BioPharma|Rasio jangkoan perantara quantumbiopharma.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
QNTM - Bathi resik|Bathi sing dikarepake Quantum BioPharma Ltd|QNTM - Pangali P/E|Kapitalisasi marang proyeksi bathi Quantum BioPharma Ltd.|QNTM - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Quantum BioPharma Limited|QNTM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Quantum BioPharma|QNTM - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan quantumbiopharma.com|QNTM - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Quantum BioPharma Ltd
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:QNTM quantumbiopharma.com
The P/S ratio determines the market value of one dollar of revenue, allowing for a business valuation independent of current earnings. This indicator measures the degree of asset overvaluation by filtering quarterly noise through daily price action. For Quantum BioPharma Ltd (QNTM), steady demand for niche ingredients creates a consistent cash flow that confirms the fundamental valuation base. Analyzing the price-to-sales chart helps identify imbalances between the issuer's market capitalization and its actual revenues.
Pesaing Quantum BioPharma Ltd
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue KVUE|Multiplikator rega marang pendapatan Verona Pharma PLC|MENS: Kapitalisasi marang pendapatan|LGND - Multiplikator P/S|AMRX: Multiplikator P/S|perrigo.com (PRGO) - Multiplikator P/S|Rasio rega marang pendapatan Alvotech SA|Rasio kapitalisasi marang pendapatan LQDA (Liquidia Corp)|Kapitalisasi marang pendapatan GLPG (Galapagos Genomics)|Kapitalisasi marang volume dodolan ANIP|MannKind Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S amphastar.com AMPH|PCRX - Rasio rega marang pendapatan|ARS Pharmaceuticals Inc (SPRY) - Kapitalisasi marang pendapatan|TBPH (Theravance) - Kapitalisasi marang pendapatan|Aquestive Corp - Rasio kapitalisasi pasar marang pendapatan|SCPH (scPharmaceuticals, Inc.) - Multiplikator P/S|Rasio rega marang pendapatan TECX|Multiplikator P/S TNXP|Koefisien rega marang pendapatan sxtchina.com|Rasio rega marang pendapatan Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rega marang dodolan|EXOZ - Rasio rega marang pendapatan|Rasio rega marang dodolan ORMP|ENTX: Multiplikator P/S|MindWalk Holdings, Inc. - Rasio kapitalisasi pasar marang pendapatan|ABVC (ABVC BioPharma Inc) - Multiplikator P/S|Multiplikator P/S Cumberland Corp|Rasio rega marang pendapatan FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Rani Therapeutics Holdings, Inc. RANI|SNYR - Kapitalisasi marang pendapatan|Rallybio Corp. - Multiplikator P/S|LEXX - Multiplikator P/S|PULM (Pulmatrix, Inc.) - Kapitalisasi marang pendapatan|Pheton Holdings - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Aptorum Group Ltd|Rasio rega marang pendapatan LYRA|Kapitalisasi marang pendapatan IBO (Impact BioMedical)|Kapitalisasi marang volume dodolan TNFA|Multiplikator P/S YCBD (cbdMD)|PRFX: Rasio kapitalisasi marang pendapatan|CYTO - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan Lipella Pharmaceuticals Inc (LIPO)|Optinose (OPTN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan PIRS|Kapitalisasi marang pendapatan PROC|PTPI (petrospharma.com) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan Qilian International Holding (QLI)|Kapitalisasi marang pendapatan Acelyrin Inc. SLRN|Rasio rega marang pendapatan TFF Pharma TFFP
